Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Cloudflare Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Cloudflare Inc trades at $361 (market cap $121.74B). The key difference: Cloudflare Inc is far larger — about 9.7× Halozyme Therapeutics Inc. Common Stock's market cap, and Cloudflare Inc is more actively traded (2,433,002 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Cloudflare Inc for 61 Days on average.
| HALO | NET | |
|---|---|---|
Market Cap | $12.58B | $121.74B |
Volume | 2,179,278 | 2,433,002 |
Sector | Health | Technology |
52-Week High | $115.22 | $359.60 |
52-Week Low | $61.63 | $160.16 |
Typical Hold Time | 1 Days | 61 Days |
Enterprise Value | $14.49B | $121.11B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cloudflare (NET) trades at $341.70, down slightly by 0.33% on the day, with a bullish technical signal from moving averages and a consensus analyst rating of 'Buy' from 70.7% of 41 analysts. The stock has beaten earnings estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -8.21%. Recent news highlights strategic partnerships and product launches, such as Cloudflare Basin and a post-quantum certificate authority, driving positive sentiment.
The outlook is mixed: strong revenue growth and strategic positioning in AI security offer upside, but high valuation multiples and persistent losses pose risks. Investors face volatility from execution challenges and competitive pressures, though analyst targets suggest moderate upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
